All blog items

Phase 3 COMET findings show the Sanofi Genzyme product delivered significantly improved efficacy and safety for the rare autosomal disorder. Investigational recombinant human lysosomal acid α-glucosidase (GAA) enzyme replacement therapy avalglucosidase alfa generated substantial clinical improvements in patients with late-onset Pompe disease (LOPD) versus alglucosidase alfa in new phase 3 findings.

Duke scientists John Franklin Rawls, PhD, and Linfa Wang, PhD, are among 65 new fellows elected to the American Academy of Microbiology

SUPPORT OFFICE HOURS REDCap Office Hours   Email redcap-docr@duke.edu to schedule a virtual session at one of the times indicated below. Tuesdays 10 AM, virtual sessions Wednesdays 10 AM, virtual sessions Thursdays 2 PM, virtual sessions Fridays 10 AM, virtual sessions   SlicerDicer Office Hours Thursdays, 2 PM, via WebEx

Research Community News iRIS/OnCore Updates DOCR News Recruitment Innovation Corner Training Opportunities Clinical Research Employee Highlights Partner Resources

Over a third of patients with diabetes and heart disease were not taking any of the three therapies proven to prevent major adverse cardiovascular events.

The two-year, $75,000 fellowship is intended to advance the recipient’s research.

The United Nations has declared February 11 the sixth International Day of Women and Girls in Science.

Dr. Misra serves as Director of Digital Health for the American Medical Association (AMA). He is an associate professor of medicine and health administration at Virginia Commonwealth University Health System, specializing in internal medicine and health informatics.

OPSD is a school-wide initiative focused on the training and support of physician-scientists.

A Duke COVID-19 study tracking the pandemic in Cabarrus County is contributing data to a statewide research network monitoring the coronavirus in sewer systems to help inform the public health response in North Carolina.